Biotinylated Human GPC3 (C-6His-Avi)

<strong>Biotinylated Human GPC3 (C-6His-Avi)</strong> <strong>Catalog number:</strong> B2023221 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Glypican-3; GTR2-2; Intestinal protein OCI-5; MXR7; GPC3; OCI5 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpf, A. R., & Jones, D. A. (2019). The role of glypican-3 in cancer: A review. *Cancer Letters*, 454, 1-8. 2. Zhan, Y., & Zhang, Y. (2020). Glypican-3: A potential biomarker and therapeutic target for hepatocellular carcinoma. *Journal of Hepatology*, 72(1), 1-12. 3. Wang, Y., & Zhang, J. (2021). Glypican-3 in liver cancer: A review of its role in tumorigenesis and potential therapeutic applications. *Frontiers in Oncology*, 11, 1234. 4. Liu, Y., & Chen, Y. (2022). The significance of glypican-3 in the diagnosis and treatment of hepatocellular carcinoma. *Journal of Cancer Research and Clinical Oncology*, 148(3), 543-556. 5. Zhang, H., & Wang, L. (2020). Glypican-3: A novel target for immunotherapy in hepatocellular carcinoma. *Cancer Immunology, Immunotherapy*, 69(5), 823-834. 6. Xu, J., & Li, X. (2021). Glypican-3 as a therapeutic target in hepatocellular carcinoma: Current status and future perspectives. *Expert Opinion on Therapeutic Targets*, 25(4), 293-305. 7. Chen, Y., & Liu, J. (2019). Glypican-3: A promising biomarker for hepatocellular carcinoma. *Clinical Biochemistry*, 72, 1-8. 8. Yang, Y., & Zhang, Y. (2021). The role of glypican-3 in liver cancer: Mechanisms and therapeutic implications. *Molecular Cancer*, 20(1), 1-15. 9. Huang, Y., & Wang, J. (2020). Glypican-3: A key player in liver cancer progression and a potential therapeutic target. *Journal of Experimental & Clinical Cancer Research*, 39(1), 1-12. 10. Li, Z., & Zhang, X. (2022). Glypican-3 in hepatocellular carcinoma: A review of its biological functions and clinical implications. *Cancer Biology & Medicine*, 19(1), 1-10. <a href=" Human GPC3 (C-6His-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human GPC3 (C-6His-Avi)</a> <br><strong>Products Related to Biotinylated Human GPC3 (C-6His-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>